Responses
Immunotherapy biomarkers
Original research
Pretreatment CT-based machine learning radiomics model predicts response in unresectable hepatocellular carcinoma treated with lenvatinib plus PD-1 inhibitors and interventional therapy
Compose a Response to This Article
Other responses
No responses have been published for this article.